Abstract: Described is a negative pressure wound therapy (NPWT) dressing that includes a backing layer, an adhesive skin contact layer; the adhesive skin contact layer being configured to detachably adhere the dressing to a dermal surface, wherein the backing layer includes a coupling member; the coupling member includes a tubing configured to connect the dressing to a negative pressure source and to a remote fluid collector.

Abstract: The present disclosure generally relates to a negative wound therapy (NPWT) system (100) comprising a mobile negative pressure device (101), a tubing assembly (105) and a non-absorbent or an absorbent dressing (104).

Abstract: Described is a negative wound therapy (NPWT) dressing that includes a backing layer and an adhesive skin contact layer, the adhesive skin contact layer being configured to detachably adhere the dressing to a dermal surface, wherein the backing layer includes a coupling member. The coupling member includes a tubing configured to connect the dressing to a negative pressure source and to a remote fluid collector.

Abstract: Described is a negative wound therapy (NPWT) dressing that includes a backing layer and an adhesive skin contact layer, the adhesive skin contact layer being configured to detachably adhere the dressing to a dermal surface, wherein the backing layer includes a coupling member. The coupling member includes a tubing configured to connect the dressing to a negative pressure source and to a remote fluid collector.

Abstract: A frame for fixation of equipment to the head of a patient during neurological diagnosis, therapy or surgery is adapted to enclose the head of the patient. The frame includes a number of mounting slots arranged in the frame. The mounting slots are adapted to receive a number of fixation pins adapted to fixate the frame to a bone in the head. The frame further includes two anterior longitudinal posts and two posterior longitudinal posts, extending along a longitudinal axis A, an anterior portion, adapted to be arranged at the anterior side of the head, the anterior portion interconnecting the two anterior longitudinal posts, and a posterior portion, adapted to be arranged at the posterior side of the head, the posterior portion interconnecting the two posterior longitudinal posts.

Abstract: A frame for fixation of equipment to the head of a patient during neurological diagnosis, therapy or surgery is adapted to enclose the head of the patient. The frame includes a number of mounting slots arranged in the frame. The mounting slots are adapted to receive a number of fixation pins adapted to fixate the frame to a bone in the head. The frame further includes two anterior longitudinal posts and two posterior longitudinal posts, extending along a longitudinal axis A, an anterior portion, adapted to be arranged at the anterior side of the head, the anterior portion interconnecting the two anterior longitudinal posts, and a posterior portion, adapted to be arranged at the posterior side of the head, the posterior portion interconnecting the two posterior longitudinal posts.

Abstract: A method for producing an oligomeric form of ?-lactalbumin which is in the molten globule-like state is described. The method suitably comprises exposing a source of ?-lactalbumin in which the ?-lactalbumin is preferably in the molten globule-like state, to an ion exchange medium which has been pre-treated with casein or an active component thereof, such as oleic acid, and recovering ?-lactalbumin in an oligomeric form therefrom. Pre-treatment of the ion exchange medium, particularly with casein derived from human milk, has been found to significantly improve yields of the oligomeric form of ?-lactalbumin and mean that it can readily isolated from readily available sources such as bovine ?-lactalbumin. This form of ?-lactalbumin is useful therapeutically, in particular as an antibacterial agent and also as an anti-cancer therapeutic.

Abstract: A biologically active complex comprising alpha-lactalbumin or a variant of alpha-lactalbumin which is in the apo folding state, or a fragment of either of any of these, and a cofactor which stabilizes the complex in a biologically active form, provided that any fragment of alpha-lactalbumin or a variant thereof comprises a region corresponding to the region of ?-lactalbumin which forms the interface between the alpha and beta domains, and further provided that when the complex comprises native alpha-lactalbumin, the cofactor is other than C18:1:9 cis fatty acid. These complexes have therapeutic applications for example in the treatment of cancer and as antibacterial agents.